Post-Operative Recovery Registry
BehavioralMulti-institutional prospective database of patients with bladder cancer undergoing radical cystectomy.
NCT Number: NCT03193970
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Observational
University of California - San Francisco, San Francisco, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
N/A
Multi-institutional prospective database of patients with bladder cancer undergoing radical cystectomy.
Time frame: 3 months
Post-surgical outcomes determined from patient-reported assessment of symptom burden using the MD Anderson Symptom Inventory (MDASI-BLC form).
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06963346
Bladder Cancer, Female Urogenital Diseases
Tampa, Florida, United States
View Trial DetailsNCT07660055
Bladder Cancer, Breast Cancer
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT07419295
Bladder Cancer, Female Urogenital Diseases
Traverse City, Michigan, United States
View Trial DetailsNCT06465069
Adnexal Diseases, Advanced Solid Tumor
Duarte, California, United States
View Trial Details